BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12181104)

  • 1. Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men.
    Teramukai S; Rohan T; Eguchi H; Oda T; Shinchi K; Kono S
    Am J Epidemiol; 2002 Aug; 156(4):344-8. PubMed ID: 12181104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study.
    Gapstur SM; Kopp P; Chiu BC; Gann PH; Colangelo LA; Liu K
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2208-16. PubMed ID: 15598782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women.
    Gram IT; Norat T; Rinaldi S; Dossus L; Lukanova A; Téhard B; Clavel-Chapelon F; van Gils CH; van Noord PA; Peeters PH; Bueno-de-Mesquita HB; Nagel G; Linseisen J; Lahmann PH; Boeing H; Palli D; Sacerdote C; Panico S; Tumino R; Sieri S; Dorronsoro M; Quirós JR; Navarro CA; Barricarte A; Tormo MJ; González CA; Overvad K; Paaske Johnsen S; Olsen A; Tjønneland A; Travis R; Allen N; Bingham S; Khaw KT; Stattin P; Trichopoulou A; Kalapothaki V; Psaltopoulou T; Casagrande C; Riboli E; Kaaks R
    Int J Obes (Lond); 2006 Nov; 30(11):1623-31. PubMed ID: 16552400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time spent walking or exercising and blood levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3): A large-scale cross-sectional study in the Japan Collaborative Cohort study.
    Wakai K; Suzuki K; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():23-7. PubMed ID: 20553077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender.
    Faupel-Badger JM; Berrigan D; Ballard-Barbash R; Potischman N
    Ann Epidemiol; 2009 Dec; 19(12):841-9. PubMed ID: 19944347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.
    Holmes MD; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):862-7. PubMed ID: 12223430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women.
    Sandhu MS; Gibson JM; Heald AH; Dunger DB; Wareham NJ
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):166-70. PubMed ID: 14744751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
    Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.
    Sarma AV; Jaffe CA; Schottenfeld D; Dunn R; Montie JE; Cooney KA; Wei JT
    Urology; 2002 Mar; 59(3):362-7. PubMed ID: 11880071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.
    Kawachi S; Takeda N; Sasaki A; Kokubo Y; Takami K; Sarui H; Hayashi M; Yamakita N; Yasuda K
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: the Rancho Bernardo Study.
    Jassal SK; von Muhlen D; Barrett-Connor E; Rosen CJ
    Osteoporos Int; 2005 Dec; 16(12):1948-54. PubMed ID: 16088361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.